Ardent Health Partners, LLC (NYSE:ARDT) Receives Average Rating of “Buy” from Analysts

Ardent Health Partners, LLC (NYSE:ARDTGet Free Report) has been assigned a consensus rating of “Buy” from the twelve research firms that are covering the company, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold rating, eight have given a buy rating and two have issued a strong buy rating on the company. The average twelve-month target price among brokerages that have covered the stock in the last year is $21.18.

A number of research firms recently weighed in on ARDT. JPMorgan Chase & Co. reissued a “neutral” rating and set a $20.00 target price on shares of Ardent Health Partners in a report on Tuesday, December 17th. Royal Bank of Canada dropped their price objective on shares of Ardent Health Partners from $23.00 to $21.00 and set an “outperform” rating on the stock in a research report on Tuesday, March 4th. Stephens restated an “overweight” rating and set a $22.00 target price on shares of Ardent Health Partners in a research note on Wednesday. Morgan Stanley decreased their price target on shares of Ardent Health Partners from $23.50 to $22.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 21st. Finally, Truist Financial cut their price objective on shares of Ardent Health Partners from $22.00 to $21.00 and set a “buy” rating for the company in a research report on Monday, January 6th.

View Our Latest Analysis on Ardent Health Partners

Hedge Funds Weigh In On Ardent Health Partners

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Point72 Asia Singapore Pte. Ltd. acquired a new stake in shares of Ardent Health Partners during the 4th quarter worth $27,000. US Bancorp DE acquired a new stake in Ardent Health Partners during the fourth quarter worth about $31,000. R Squared Ltd bought a new position in Ardent Health Partners in the 4th quarter valued at about $37,000. BNP Paribas Financial Markets bought a new position in Ardent Health Partners in the 3rd quarter valued at about $42,000. Finally, New York State Common Retirement Fund acquired a new position in shares of Ardent Health Partners in the 4th quarter valued at approximately $48,000.

Ardent Health Partners Trading Up 0.1 %

Shares of ARDT opened at $13.18 on Tuesday. The firm has a 50-day moving average of $14.41 and a 200-day moving average of $16.23. Ardent Health Partners has a one year low of $12.87 and a one year high of $20.72. The company has a debt-to-equity ratio of 0.78, a current ratio of 1.91 and a quick ratio of 1.78.

Ardent Health Partners (NYSE:ARDTGet Free Report) last posted its quarterly earnings results on Wednesday, February 26th. The company reported $0.81 EPS for the quarter, topping analysts’ consensus estimates of $0.50 by $0.31. The business had revenue of $1.61 billion for the quarter, compared to the consensus estimate of $1.48 billion. Sell-side analysts anticipate that Ardent Health Partners will post 1.23 earnings per share for the current year.

About Ardent Health Partners

(Get Free Report

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.

See Also

Analyst Recommendations for Ardent Health Partners (NYSE:ARDT)

Receive News & Ratings for Ardent Health Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ardent Health Partners and related companies with MarketBeat.com's FREE daily email newsletter.